5.23 USD
↗ 0.00 (0.00%)PRE MARKET (AS OF 07:31 PM EDT)
Atea Pharmaceuticals, Inc. Common Stock
AVIRNASDAQ • USD
Market: OPEN
Atea Pharmaceuticals, Inc. Common Stock (AVIR) trades at $5.23 per share. Both sides of the analysis point lower: technicals flash "Sell" and fundamentals confirm with a "Sell" reading. Key drivers include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. On the valuation side, AVIR appears attractively valued relative to sector peers across key multiples.
Technical & fundamental data as of Sep 15, 2026.
Open?$5.30
High?$5.30
Low?$5.13
Prev. Close?$5.23
Volume?184.0K
Avg. Volume?253.6K
VWAP?$5.20
Rel. Volume?0.73x
Bid / Ask
Bid?$4.43 × 100
Ask?$6.27 × 100
Spread?$1.84
Midpoint?$5.35
Valuation & Ratios
Market Cap?419.5M
Shares Out?80.2M
Float?61.1M
Float %?76.2%
P/E Ratio?N/A
P/B Ratio?2.05
EPS?-$2.06
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Atea Pharmaceuticals Inc is a late-stage clinical biopharmaceutical company focused on the discovery, development, and commercialization of oral antiviral therapies for serious viral diseases. The company's pipeline includes a regimen of bemnifosbuvir and ruzasvir for the treatment of hepatitis C virus (HCV) infection and AT-587 for the treatment of hepatitis E virus (HEV) infection.
Employees
55
Market Cap
426.7M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2020-10-30
Address
225 FRANKLIN STREET
BOSTON, MA 02110
Phone: (857) 284-8891
BOSTON, MA 02110
Phone: (857) 284-8891
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?– Neutral(0/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?88
Momentum?50
Short Sent.?28
Piotroski F-Score?0/9Weak
Altman Z-Score?3.75Safe
Confidence?48%Low
Short InterestVery High
Short % of Float?12.55%High
Short Interest?7.7M
Days to Cover?41.2
Free Float61.1M
Avg Daily Volume186.2K
Settlement Date2026-08-31
Financial Health
Current Ratio?8.13Strong
Quick Ratio?8.13Strong
Cash Ratio?2.72Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?2.05CHEAP▾
Peers100
S&P73
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-1.9CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-81.0%WEAK▾
S&P3
ROA?-71.2%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-152073000
Enterprise Value?$342.9M
Fundamentals ratios updated end of day